The grand promise of artificial intelligence has always been the benefit to humanity. We were promised climate change solutions and cures for disease. Instead, it feels like the market is swamped with chatbots and large language models (LLMs) built on scraped and stolen intellectual property, designed to take your job or drive you to delusions. But a London start-up has been diligently working for years to create something that could change the future — for good.
Basecamp Research is the creator of EDEN — a cluster of AI models trained on DNA and evolutionary patterns that can algorithmically deduce new drugs and gene therapies to treat cancers and the rarest of genetic diseases. It is trained on BaseData, the company’s genomics dataset. And it’s backed by the computing power of Nvidia, the tech giant powering the latest AI innovations.
